Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53
More than 50% of human cancers contain p53 gene mutations and as a result accumulate altered forms of the full-length p53 protein. Although certain tumor types expressing mutant p53 protein have a poor prognostic process, the precise role of mutant p53 protein in highly malignant tumor cells is not...
Furkejuvvon:
| Publikašuvnnas: | Mol Cell Biol |
|---|---|
| Váldodahkkit: | , , , , , , |
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis
2003
|
| Fáttát: | |
| Liŋkkat: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140653/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12482984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/MCB.23.1.322-334.2003 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|